Company DexCom, Inc.

Equities

DXCM

US2521311074

Medical Equipment, Supplies & Distribution

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Group companies

Sector

Sales per Business

Sales per region

Ratings for DexCom, Inc.

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-25 pm EDT			After market 05:07:00 pm
138 ^USD	+0.10%		126.8	-8.16%

11:00pm	DexCom Q1 Non-GAAP Earnings, Revenue Rise; 2024 Revenue Guidance Gains; Shares Fall After Hours	MT
10:26pm	Earnings Flash (DXCM) DEXCOM Posts Q1 EPS $0.32, vs. Street Est of $0.27	MT

DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals.

The United States accounts for 72.5% of net sales.

Number of employees: 9,550

USD in Million	2022	Weight	2023	Weight	Delta
Distributor 85.5 %	2,471	84.9 %	3,096	85.5 %	+25.29%
Direct 14.5 %	439	15.1 %	527	14.5 %	+19.98%

USD in Million	2022	Weight	2023	Weight	Delta
United States 72.5 %	2,142	73.6 %	2,625	72.5 %	+22.56%
International 27.5 %	768	26.4 %	997	27.5 %	+29.85%

Managers	Title	Age	Since
Kevin Sayer CEO	Chief Executive Officer	66	07-10-31
Jereme Sylvain DFI	Director of Finance/CFO	44	18-08-31
Girish Naganathan CTO	Chief Tech/Sci/R&D Officer	47	22-09-30
Shelly Selvaraj CTO	Chief Tech/Sci/R&D Officer	65	16-04-30
Jacob Leach COO	Chief Operating Officer	46	04-02-29
Don Abbey CTO	Chief Tech/Sci/R&D Officer	57	16-04-30
Andrew Balo CTO	Chief Tech/Sci/R&D Officer	76	02-01-31
Sean Christensen IRC	Investor Relations Contact	-	-
Paul Flynn PRN	Corporate Officer/Principal	55	15-09-30
Sadie Stern HRO	Human Resources Officer	49	20-08-31

Members of the board	Title	Age	Since
Nick Augustinos BRD	Director/Board Member	65	09-11-19
Mark Foletta BRD	Director/Board Member	63	14-11-18
Eric Topol BRD	Director/Board Member	69	09-07-08
Kevin Sayer CEO	Chief Executive Officer	66	07-10-31
Steven Altman BRD	Director/Board Member	62	13-11-06
Bridgette Heller BRD	Director/Board Member	62	19-09-12
Richard Collins BRD	Director/Board Member	67	17-03-08
Kyle Malady BRD	Director/Board Member	56	20-10-10
Barbara Kahn BRD	Director/Board Member	71	11-03-31
Karen Dahut BRD	Director/Board Member	60	20-08-10

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	417,825,556	384,097,133 ( 91.93 %)	21,800,000 ( 5.217 %)	91.93 %

Name	Equities	%	Valuation
Vanguard Fiduciary Trust Co. 11.53 %	44,467,463	11.53 %	6 168 M $
BlackRock Advisors LLC 6.767 %	26,089,307	6.767 %	3 619 M $
Baillie Gifford & Co. 4.285 %	16,520,313	4.285 %	2 291 M $
STATE STREET CORPORATION 4.202 %	16,198,598	4.202 %	2 247 M $
Capital Research & Management Co. (Global Investors) 3.968 %	15,296,032	3.968 %	2 122 M $
Sands Capital Management LLC 3.906 %	15,058,806	3.906 %	2 089 M $
Capital Research & Management Co. (World Investors) 2.407 %	9,278,685	2.407 %	1 287 M $
Geode Capital Management LLC 2.313 %	8,917,255	2.313 %	1 237 M $
Fidelity Management & Research Co. LLC 2.102 %	8,104,234	2.102 %	1 124 M $
Teachers Advisors LLC 1.943 %	7,492,292	1.943 %	1 039 M $

DexCom, Inc.

6340 Sequence Drive

92121, San Diego

+858 200 0200

http://www.dexcom.com

Name	Category and Sector
Dexcom Operating Ltd. Dexcom Operating Ltd. Financial ConglomeratesFinance Part of DexCom, Inc., DexCom Operating Ltd. functions as an investment holding British company. The private company is based in Reading, UK and was founded in 2015.	Financial Conglomerates

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

137.9 USD

Average target price

149.3 USD

Spread / Average Target

+8.28%

Consensus

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
DEXCOM, INC.	+11.22%	54.6B
ABBOTT LABORATORIES	-2.92%	185B
MEDTRONIC PLC	-3.80%	107B
BECTON, DICKINSON AND COMPANY	-5.48%	67.55B
CENCORA, INC.	+16.74%	47.42B
HOYA CORPORATION	+3.86%	42.24B
WEST PHARMACEUTICAL SERVICES, INC.	+4.56%	28.24B
METTLER-TOLEDO INTERNATIONAL, INC.	+1.64%	26.42B
TERUMO CORPORATION	+12.40%	25.66B
ZIMMER BIOMET HOLDINGS, INC.	-1.60%	24.9B

Other Medical Equipment, Supplies & Distribution